vaccine
-
Covid-19 second wave: What have we learned so far from around the world
Jimmy Whitworth, The Conversation
-
A statistician explains: What does ‘90% efficacy’ for a Covid-19 vaccine mean?
Atanu Biswas
-
Covid-19 vaccines are being developed in a record time. Is this reason to be wary?
Mark Toshner, The Conversation
-
Interview: Why Covid-19 vaccines should be a global public good and not be hoarded by rich countries
Smitha Nair
-
Rich nations may use patents to cut off easy access to Covid-19 vaccines in developing countries
Anoo Bhuyan, IndiaSpend.com
-
How do Pfizer and Moderna vaccines work? And why do they need to be kept so cold?
Sanjay Mishra, The Conversation
-
Watch: Boston professor sings a song for Covid-19 vaccine based on Dolly Parton’s ‘Jolene’
Scroll Staff
-
How should countries roll out Covid-19 vaccine? France and the UK have two different ideas
Laurence Roope, The Conversation Philip Clarke, The Conversation Raymond Duch, The Conversation
-
Pfizer’s Covid-19 vaccine 95% effective in phase-3 study, says company
Scroll Staff
-
India working on strategy to procure Pfizer vaccine despite cold storage challenges, says Centre
Scroll Staff
-
Six questions (and answers) about Moderna and Pfizer’s vaccines showing promising results
Simon Kolstoe, The Conversation
-
Moderna and Pfizer Covid vaccines currently unaffordable for India: Medical expert Gagandeep Kang
Scroll Staff
-
Pfizer vaccine’s success is great news – but don’t expect life to ‘return to normal by spring’
Sarah Pitt, The Conversation
-
How Pfizer’s Covid vaccine could be a real game-changer, plus nine more weekend reads
Scroll Staff
-
We know Pfizer’s Covid vaccine works. But how well it works is still unknown
Anne Moore, The Conversation
-
Covid-19 vaccine: Common people may have to wait till 2022, says AIIMS director
Scroll Staff
-
Watch: Scientists share behind-the-scenes processes of developing the Covid-19 vaccine
Scroll Staff
-
Coronavirus: Delhi records over 6,500 cases for second consecutive day
Scroll Staff
-
Coronavirus will make rapid development of drugs the norm, says Gates Foundation president
Govindraj Ethiraj, IndiaSpend.com
-
Coronavirus: First-generation of vaccines is likely to be imperfect, says UK official
Scroll Staff